Clinical Trial Update: Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG [Phase 2]

View source ↗

Summary

This is a completed Phase 2 trial evaluating autologous followed by nonmyeloablative allogeneic transplantation using total lymphoid irradiation (TLI) and antit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Antithymocyte Globulin (ATG) (antithymocyte globulin)

Snippet

Sponsor: Stanford University | Conditions: Transplantation, Homologous, Transplantation, Autologous | Phase 2 | Status: COMPLETED | Results posted: 2017-10-20